Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · IEX Real-Time Price · USD
2.140
-0.120 (-5.31%)
At close: Jul 19, 2024, 4:00 PM
2.150
+0.010 (0.47%)
Pre-market: Jul 22, 2024, 7:34 AM EDT
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $430.95 million as of July 22, 2024. Its market cap has increased by 904.55% in one year.
Market Cap
430.95M
Enterprise Value
363.38M
1-Year Change
904.55%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has decreased from $690.43M to $430.95M, a decrease of -37.58%. That is a compound annual growth rate of -11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 400.20M | 20.94% |
| Dec 29, 2023 | 330.90M | 134.51% |
| Dec 30, 2022 | 141.10M | -68.52% |
| Dec 31, 2021 | 448.20M | -55.28% |
| Dec 31, 2020 | 1.00B | 45.16% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 448.94M |
| Altimmune | 445.27M |
| Nano-X Imaging | 441.43M |
| Nkarta | 437.60M |
| Kyverna Therapeutics | 431.58M |
| Aura Biosciences | 429.54M |
| Health Catalyst | 428.59M |
| Ocugen | 427.21M |